false0000313616 0000313616 2020-03-31 2020-03-31 0000313616 dhr:FloatingRateSeniorNotesDue2022Member 2020-03-31 2020-03-31 0000313616 dhr:A1.2SeniorNotesDue2027Member 2020-03-31 2020-03-31 0000313616 us-gaap:CommonStockMember 2020-03-31 2020-03-31 0000313616 us-gaap:SeriesAPreferredStockMember 2020-03-31 2020-03-31 0000313616 dhr:A1.35SeniorNotesDue2039Member 2020-03-31 2020-03-31 0000313616 dhr:A1.7SeniorNotesDue2022Member 2020-03-31 2020-03-31 0000313616 dhr:A1.8SeniorNotesDue2049Member 2020-03-31 2020-03-31 0000313616 dhr:A0.75SeniorNotesDue2031Member 2020-03-31 2020-03-31 0000313616 dhr:A1.7SeniorNotesDue2024Member 2020-03-31 2020-03-31 0000313616 dhr:A2.1SeniorNotesDue2026Member 2020-03-31 2020-03-31 0000313616 dhr:A2.5SeniorNotesDue2030Member 2020-03-31 2020-03-31 0000313616 dhr:A0.2SeniorNotesDue2026Member 2020-03-31 2020-03-31 0000313616 dhr:A0.45SeniorNotesDue2028Member 2020-03-31 2020-03-31 0000313616 dhr:A2.5SeniorNotesDue2025Member 2020-03-31 2020-03-31 0000313616 us-gaap:SeriesBPreferredStockMember 2020-03-31 2020-03-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________
FORM 8-K/A
(Amendment No. 1)
_____________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 31, 2020
_____________________________________________
DHRLOGOFOR8KSA50.JPG
DANAHER CORPORATION
 
(Exact Name of Registrant as Specified in Its Charter)
 
__________________
Delaware
 
001-08089
 
59-1995548
(State or Other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
 
 
2200 Pennsylvania Avenue, NW
 
 
 
20037-1701
Suite 800W
 
 
 
Washington,
DC
 
 
 
(Address of Principal Executive Offices)
 
 
 
(Zip Code)
202-828-0850
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
_____________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, $0.01 par value
DHR
New York Stock Exchange
4.75% Mandatory Convertible Preferred Stock, Series A, without par value
DHR.PRA
New York Stock Exchange
5.00% Mandatory Convertible Preferred Stock, Series B, without par value
DHR.PRB
New York Stock Exchange
Floating Rate Senior Notes due 2022
DHR F 06/30/22
New York Stock Exchange
1.700% Senior Notes due 2022
DHR 1.7 01/04/22
New York Stock Exchange
1.700% Senior Notes due 2024
DHR 1.7 03/30/24
New York Stock Exchange
2.500% Senior Notes due 2025
DHR 2.5 07/08/25
New York Stock Exchange
0.200% Senior Notes due 2026
DHR 0.2 03/18/26
New York Stock Exchange
2.100% Senior Notes due 2026
DHR 2.1 09/30/26
New York Stock Exchange
1.200% Senior Notes due 2027
DHR 1.2 06/30/27
New York Stock Exchange
0.450% Senior Notes due 2028
DHR 0.45 03/18/28
New York Stock Exchange
2.500% Senior Notes due 2030
DHR 2.5 03/30/30
New York Stock Exchange
0.750% Senior Notes due 2031
DHR 0.75 09/18/31
New York Stock Exchange
1.350% Senior Notes due 2039
DHR 1.35 09/18/39
New York Stock Exchange
1.800% Senior Notes due 2049
DHR 1.8 09/18/49
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  






Item 2.01    Completion of Acquisition or Disposition of Assets.
On April 1, 2020, Danaher Corporation (the “Company”) filed a Current Report on Form 8-K reporting that, on March 31, 2020, the Company completed the acquisition of certain equity interests and assets, and assumption of certain liabilities, of the Biopharma business of the Life Sciences business of the General Electric Company (the “Biopharma Business”). This Amendment No. 1 amends the Current Report on Form 8-K filed on April 1, 2020 to provide the pro forma financial information required by Item 9.01 of Form 8-K, which was omitted from the initial filing in reliance on Items 9.01(a)(4) and 9.01(b)(2) of Form 8-K.
Item 9.01    Financial Statements and Exhibits.
(a)    Pro Forma Financial Information.
The unaudited pro forma condensed combined financial statements of the Company with respect to the transaction described in Item 2.01 are filed as Exhibit 99.1 to this amendment and incorporated herein by reference. 
(b)    Exhibits:
Exhibit Number
 
Exhibit Description
99.1
 
104
 
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
DANAHER CORPORATION
 
 
By:
/s/ Robert S. Lutz
Name:
Robert S. Lutz
Title:
Senior Vice President and Chief Accounting Officer
Date: May 21, 2020



Danaher (NYSE:DHR)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Danaher Charts.
Danaher (NYSE:DHR)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Danaher Charts.